M\u0130LL\u0130YET, 3 Mart 2015<\/b><\/p>\n
T\u00fcrk Eczac\u0131lar\u0131 Birli\u011fi, MS hastalar\u0131n\u0131n kulland\u0131\u011f\u0131 ila\u00e7larda 4 ayd\u0131r s\u0131k\u0131nt\u0131 ya\u015fand\u0131\u011f\u0131 iddialar\u0131na yan\u0131t verdi. Genel Sekreter Harun K\u0131z\u0131lay, Gilenya ve Tecfidera’n\u0131n temini konusunda bir s\u0131k\u0131nt\u0131 olmad\u0131\u011f\u0131n\u0131 ancak Sosyal G\u00fcvenlik Kurumu’nun Tysabri isimli ilac\u0131n kullan\u0131m\u0131na dair de\u011fi\u015fiklik yapt\u0131\u011f\u0131n\u0131 a\u00e7\u0131klad\u0131.<\/p>\n
K\u0131z\u0131lay, “Gilenya isimli ila\u00e7, piyasada 2 y\u0131ld\u0131r ruhsatl\u0131 ama geri \u00f6deme listesinde olmad\u0131\u011f\u0131 i\u00e7in temininde s\u0131k\u0131nt\u0131lar ya\u015fansa da biz TEB olarak yurtd\u0131\u015f\u0131ndan getiriyorduk. \u015eimdi SGK bu ilac\u0131 da geri \u00f6demeye ald\u0131. Ancak \u00fcretici firma T\u00fcrkiye genelinde t\u00fcm eczanelerde sat\u0131labilmesi i\u00e7in 3 ay s\u00fcre istemi\u015f. Bu 3 ayl\u0131k zaman diliminde biz TEB olarak ilac\u0131 yurtd\u0131\u015f\u0131ndan getirmeye devam edece\u011fiz. Tysabri adl\u0131 ilac\u0131n kullan\u0131m ko\u015fulu de\u011fi\u015fti. Hastan\u0131n bu ilac\u0131 alabilmesi i\u00e7in \u00f6nce Gilenya kullanmas\u0131 \u015fart\u0131 getirildi. Tedirginli\u011fimizi resmi bir yaz\u0131 ile SGK’ye bildirdik” dedi.<\/p>\n
T\u00fcrkiye’de 40 bin MS (Multipl Skleroz) hastas\u0131 bulunuyor. Uzmanlar MS’e kar\u015f\u0131 koruyucu tedavi konusunda son y\u0131llarda \u00f6nemli mesafeler al\u0131nd\u0131\u011f\u0131n\u0131, d\u00fczenli kullan\u0131lan ila\u00e7lar sayesinde ataklar\u0131n engellenebildi\u011fine dikkat \u00e7ekiyor. Hastalarda kal\u0131c\u0131 hasarlar olu\u015fmamas\u0131 i\u00e7in ila\u00e7lar\u0131n hayati \u00f6nemde.<\/p>\n","protected":false},"excerpt":{"rendered":"
M\u0130LL\u0130YET, 3 Mart 2015 T\u00fcrk Eczac\u0131lar\u0131 Birli\u011fi, MS hastalar\u0131n\u0131n kulland\u0131\u011f\u0131 ila\u00e7larda 4 ayd\u0131r s\u0131k\u0131nt\u0131 ya\u015fand\u0131\u011f\u0131 iddialar\u0131na yan\u0131t verdi. Genel Sekreter...<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[62],"tags":[],"class_list":["post-4742","post","type-post","status-publish","format-standard","hentry","category-sagliktan-haberler"],"aioseo_notices":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack-related-posts":[],"_links":{"self":[{"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=\/wp\/v2\/posts\/4742","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=4742"}],"version-history":[{"count":1,"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=\/wp\/v2\/posts\/4742\/revisions"}],"predecessor-version":[{"id":4743,"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=\/wp\/v2\/posts\/4742\/revisions\/4743"}],"wp:attachment":[{"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=4742"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=4742"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=4742"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}